Status | Study |
RECRUITING |
Study Name: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III) Condition: Epidermolysis Bullosa Date: 2023-04-20 Interventions: Allogeneic dermal ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs) |
RECRUITING |
Study Name: EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) Condition: Epidermolysis Bullosa Date: 2023-01-23 Interventions: EB-101 autologous RDEB keratinocytes isolated from skin biopsies and transduced with a recombinant retrovirus containing a full-length COL7A1 expre |
Recruiting |
Study Name: Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa Condition: Epidermolysis Bullosa Date: 2017-02-27 Interventions: Drug: Oleogel-S10 10% birch ba |
Recruiting |
Study Name: Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa Condition: Epidermolysis Bullosa Date: 2016-05-18 Interventions: Drug: topical BPM31510 3.0% Cream Application of drug to lesions of epidermolysis bullosa |
Recruiting |
Study Name: Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa Condition: Dystrophic Epidermolysis Bullosa Date: 2015-10-16 Interventions: Other: Allogeneic mesenchymal stem cells |
Active, not recruiting |
Study Name: Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa Condition: Epidermolysis Bullosa Date: 2015-07-28 Interventions: Drug: Zorblisa (SD-101-6.0) cream applied topically once a day to the entire body for 1440 days (48 mont |
Not yet recruiting |
Study Name: Diacerin for the Treatment of Epidermolysis Bullosa Simplex Condition: Epidermolysis Bullosa Simplex Date: 2015-05-27 Interventions: Drug: Diacerin cream Diacerin tablet solubule in ultraphil cream |
Active, not recruiting |
Study Name: ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa Condition: Epidermolysis Bullosa Date: 2015-02-13 Interventions: Drug: SD-101-6.0 cream applied |
Active, not recruiting |
Study Name: Open Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa Condition: Epidermolysis Bullosa Date: 2014-03-12 Interventions: Drug: SD-101 dermal cream (6%) applied topically once a day to the entire body for the duration of the s |
Completed |
Study Name: Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa Condition: Epidermolysis Bullosa Date: 2013-12-12 Interventions: Drug: 3% SD-101 dermal cream a |